Human Papillomavirus Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029
Human papillomavirus is the lead cause of several types of cancers such as vulvar cancer, penile cancer, vaginal cancer, and anal cancer among others. The infection of human papillomavirus can be completely avoided if the patient undergoes proper vaccinations. This has thus been the chief driving factor for the development of the global human papillomavirus vaccine market in recent years.
The vendor landscape of the global human papillomavirus vaccine market is a fragmented one because of the presence of several notable brands operating in the marketspace. The companies are expected to spend million on the development of newer drugs and vaccines to bring down the prevalence of human papillomavirus. Thus, the competition in the market is expected to intensify in the coming years of the projection period ranging from 2019 to 2029.
Some of the key players in the global market are Serum Institute of India Pvt. Ltd., AstraZeneca, Sanofi, Johnson & Johnson, Merck & Co. Inc., and GlaxoSmithKline Plc among others.
There are several factors that are having a highly positive influence on the overall development of the global human papillomavirus vaccine market. One of the key driving factor for the development of the market has been growing number of patients getting affected by it. Over 100 various types of human papillomavirus have been identified. As per the recent findings by the Centre for Disease Control in America, human papillomavirus is one of the most prevalent disease transmitted via sexual interaction. Moreover, growing prevalence of several types of cancer is also expected to drive the growth of the global human papillomavirus vaccine market in the near future.
The study by CDC further states that more than 60% of penile cancers, 70% of vaginal and vulvar cancers, and 90% of cervical and anal cancers are a result of human papillomavirus in the United States. Such high level of patient base is thus creating a strong groundwork for the development of the human papillomavirus vaccine.
In addition to this, in recent years, there has been a growing awareness about the use of human papillomavirus vaccine. Governments and healthcare organizations are consistently spreading awareness about the use of these vaccines and thus helping to push the development of the global market.
The global market for human papillomavirus vaccine market has five key geographical segments that allow the readers understand the overall working dynamics of its regional landscape. These regions are North America, Latin America, Europe, Middle East and Africa, and Asia Pacific. Of these, currently, the global human papillomavirus vaccine is being dominated by the regional segment of North America. The growth of the market is spurred by recent and quicker approvals provided to the latest drugs treating human papillomavirus. In addition to this, the early availability of newer drugs and technologies is also expected to help in increased adoption of the market.
On the other hand, the regional segment of Asia Pacific is expected to show most promise over the course of the given forecast period of 2019 to 2029. The regional segment is growing at a break neck pace because of the increasing investment levels for the development of domestic healthcare infrastructure in emerging economies such as India and China. Moreover, a larger patient pool in this region is also helping to push the development of the Asia Pacific market for human papillomavirus vaccine in the upcoming years of the forecast period.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report